Quantum computing has that rare quality in investing: it's simultaneously the future and perpetually a few years away. But the timeline may finally be firming up. The first fault-tolerant quantum computers could arrive around 2028 or 2029, according to expectations cited in The Daily Upside. That's the milestone everyone in the sector has been pointing toward, the moment when quantum machines become reliable enough to actually do useful work.
The catch, as always, is commercial adoption. Nobody knows exactly when quantum computing turns into a real business rather than a very expensive science project. Which leaves investors with a familiar question: how do you get exposure to a technology that might change everything, without betting the farm on any single company getting there first?
Two ETFs offer two very different answers. The Defiance Quantum ETF (NASDAQ: QTUM) takes the broad approach, while the WisdomTree Quantum Computing Fund (NYSE: WQTM) leans much harder into the pure-play quantum names.
The Broad Approach: QTUM
QTUM tracks the BlueStar Machine Learning and Quantum Computing Index, which covers companies involved in quantum computing, machine learning, computing chips and related software. It held 90 stocks and has $5.74 billion in net assets, with an annual expense ratio of 0.40%.
Here's the thing about QTUM: its portfolio extends well beyond pure-play quantum developers. Global Unichip represents 2.33% of assets, currently the largest holding. Horizon Quantum Holdings Ltd (NASDAQ: HQ) represents 1.87%, and Palantir Technologies Inc (NASDAQ: PLTR) represents 1.84%.
That breadth offers exposure to the wider computing ecosystem, but it cuts both ways. QTUM's performance can depend on machine learning, software and semiconductor trends rather than quantum breakthroughs alone. If quantum stalls but AI keeps booming, QTUM still has a story. If quantum booms but semiconductors slump, well, that's a different problem.
The numbers tell a story of their own. QTUM returned 36% year to date, despite an 8% decline over the preceding three months. That contrast highlights the volatility investors may face even in a diversified portfolio. Broad exposure doesn't mean smooth sailing.
The Direct Bet: WQTM
WQTM allocates more of its portfolio to companies actually developing quantum technology. IonQ Inc (NYSE: IONQ) represents 6.1% of assets, Quantinuum Inc (NASDAQ: QNT) 5.6%, Rigetti Computing Inc (NASDAQ: RGTI) 5.2% and D-Wave Quantum Inc (NASDAQ: QBTS) 4.8%. IBM (NYSE: IBM), Microsoft Corp (NASDAQ: MSFT) and Amazon.com, Inc (NASDAQ: AMZN) provided exposure to larger technology businesses as well.
The fund had approximately $346 million in assets and charged a 0.45% annual expense ratio.
Those larger positions in quantum specialists could make WQTM more responsive to technical breakthroughs and commercial contracts. When IonQ announces a new error-correction milestone or Rigetti lands a government deal, WQTM feels it more directly than QTUM would. But those same companies face substantial uncertainty over error correction, scalability and the timing of revenue growth. This is not a fund for the faint of heart.
The Question That Actually Matters
Quantum computers could eventually support drug discovery, materials science, financial modelling and supply-chain optimization. They are expected to complement conventional CPUs and GPUs, not simply replace them, according to The Daily Upside. That's an important framing. Quantum isn't coming for your laptop. It's coming for the problems your laptop can't solve.
For investors, QTUM offers broader exposure to computing and machine learning, while WQTM tilts more heavily toward quantum developers. Neither guarantees gains if the technology takes longer than expected to become commercially useful. And it might. Timelines in this sector have a habit of slipping.
The next test is whether progress in error correction and practical computing applications translates into repeatable customer demand and sustainable revenue. Until then, quantum ETFs remain a bet on an emerging technology rather than an established commercial market. That's not a reason to avoid them. It's just a reason to know what you're buying.